Parr McKnight Wealth Management Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-26,371
Closed -$2.51M – 218
2025
Q4
$2.51M Buy
26,371
+938
+4% +$92K 0.33% 95
2025
Q3
$2.48M Buy
25,433
+979
+4% +$101K 0.33% 97
2025
Q2
$2.63M Buy
24,454
+480
+2% +$48.6K 0.36% 91
2025
Q1
$2.42M Buy
23,974
+29
+0.1% +$2.92K 0.35% 94
2024
Q4
$2.14M Buy
+23,945
New +$2.11M 0.31% 94

Other funds holding BSX

Parr McKnight Wealth Management Group's BSX Position: Q1 2026 in Review

Parr McKnight Wealth Management Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 26,371 shares — an estimated $2.51M sold.

Parr McKnight Wealth Management Group first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $2.63M in Q2 2025. 1,683 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Parr McKnight Wealth Management Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Parr McKnight Wealth Management Group sold 26,371 Boston Scientific shares in Q1 2026, an estimated $2.51M.
  • Parr McKnight Wealth Management Group first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
  • Parr McKnight Wealth Management Group's Boston Scientific position peaked at $2.63M in Q2 2025.
  • 1,683 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Parr McKnight Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.